Archives of Pediatric Infectious Diseases

Published by: Kowsar
Uncorrected Proof scheduled for 7 (1)

Candidemia in the Neonatal Intensive Care Unit: Insights on Epidemiology and Antifungal Drug Susceptibility Patterns

Dina M. Hassan 1 , Reham H. A. Yousef 1 , Walaa A. Abu Elhamed 2 , Aliaa A. Ali 2 and Lamiaa A. Madkour 3 , *
Authors Information
1 Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
2 Pediatrics and Neonatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
3 Medical Microbiology and Immunology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Article information
  • Archives of Pediatric Infectious Diseases: In Press (In Press); e81090
  • Published Online: December 5, 2018
  • Article Type: Research Article
  • Received: June 21, 2017
  • Revised: September 15, 2017
  • Accepted: September 25, 2018
  • DOI: 10.5812/pedinfect.81090

To Cite: Hassan D M, Yousef R H A, Abu Elhamed W A, Ali A A, Madkour L A. Candidemia in the Neonatal Intensive Care Unit: Insights on Epidemiology and Antifungal Drug Susceptibility Patterns, Arch Pediatr Infect Dis. Online ahead of Print ; In Press(In Press):e81090. doi: 10.5812/pedinfect.81090.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnote
References
  • 1. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014;5(1):161-9. doi: 10.4161/viru.26187. [PubMed: 24157707]. [PubMed Central: PMC3916370].
  • 2. Benjamin DJ, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117(1):84-92. doi: 10.1542/peds.2004-2292. [PubMed: 16396864].
  • 3. Chen J, Jiang Y, Wei B, Ding Y, Xu S, Qin P, et al. Epidemiology of and risk factors for neonatal candidemia at a tertiary care hospital in western China. BMC Infect Dis. 2016;16(1):700. doi: 10.1186/s12879-016-2042-9. [PubMed: 27884125]. [PubMed Central: PMC5121934].
  • 4. Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012;136(6):997-1003. [PubMed: 23391796]. [PubMed Central: PMC3612330].
  • 5. Elguezabal N, Lopitz-Otsoa F, Lain A, de Larrinoa IF, Moragues MD, Ponton J. Serodiagnosis of mycoses using recombinant antigens. Mycopathologia. 2005;160(2):97-109. doi: 10.1007/s11046-005-0144-9. [PubMed: 16170604].
  • 6. Juyal D, Kotian S, Sangwan J, Rathaur VK, Sharma N. Clinico-epidemiological profile, risk factors, and prognosis of neonatal candidemia due to Candida parapsilosis: An emerging threat to neonates. Int J Health Allied Sci. 2014;3(2):100. doi: 10.4103/2278-344X.132694.
  • 7. McGinnis MR. Laboratory handbook of medical mycology. New York: Academic Press; Yeast Identification; 1980. p. 337-73.
  • 8. National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts: Approved guideline M44-. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards; 2004.
  • 9. Sanita PV, Mima EG, Pavarina AC, Jorge JH, Machado AL, Vergani CE. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):562-9. doi: 10.1016/j.oooo.2013.07.002. [PubMed: 24055150].
  • 10. Negri M, Henriques M, Svidzinski TI, Paula CR, Oliveira R. Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization. J Clin Lab Anal. 2009;23(5):324-30. doi: 10.1002/jcla.20337. [PubMed: 19785043].
  • 11. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, et al. Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14(3):164-76. doi: 10.1016/j.drup.2011.01.004. [PubMed: 21353623].
  • 12. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; 4th informational supplement. CLSI document M27-S4. Wayne: Clinical and Laboratory Standards Institute; 2012.
  • 13. Kulkarni VA, Bhadade AA, Putta SD. Candidemia profile and antifungal drugs susceptibility pattern in neonatal intensive care unit patients in a tertiary care teaching institute in Maharashtra. Ann Pathol Lab Med. 2017;4(1):A113-8. doi: 10.21276/APALM.2017.1000.
  • 14. Jain A, Rawat SK, Rai A. Rising incidence of non-albicans Candida and changing susceptibility pattern of bloodstream Candida isolates in neonates. J Clin Diagn Res. 2017;11(11). doi: 10.7860/JCDR/2017/29492.10804.
  • 15. Rao MS, Surendernath M, Sandeepthi M. Prevalence of neonatal candidemia in a tertiary care institution in Hyderabad, South India. Int J Res Med Sci. 2017;2(3):1016-9. doi: 10.5455/2320-6012.ijrms20140858.
  • 16. Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of non-albicans Candida species in neonatal candidemia. N Am J Med Sci. 2013;5(9):541-5. doi: 10.4103/1947-2714.118919. [PubMed: 24251272]. [PubMed Central: PMC3818827].
  • 17. Yadav S, Dahiya S, Budhani D. Candidemia in neonatal intensive care unit: A cause of concern. Int J Res Med Sci. 2017;5(5):2165-7. doi: 10.18203/2320-6012.ijrms20171862.
  • 18. Chang YJ, Choi IR, Shin WS, Lee JH, Kim YK, Park MS. The control of invasive Candida infection in very low birth weight infants by reduction in the use of 3rd generation cephalosporin. Korean J Pediatr. 2013;56(2):68-74. doi: 10.3345/kjp.2013.56.2.68. [PubMed: 23482686]. [PubMed Central: PMC3589593].
  • 19. Kelly MS, Benjamin DJ, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol. 2015;42(1):105-17. viii-ix. doi: 10.1016/j.clp.2014.10.008. [PubMed: 25677999]. [PubMed Central: PMC4328135].
  • 20. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: Data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695-703. doi: 10.1086/599039. [PubMed: 19441981].
  • 21. Garzillo C, Bagattini M, Bogdanovic L, Di Popolo A, Iula VD, Catania MR, et al. Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: A case-control study. Ital J Pediatr. 2017;43(1):10. doi: 10.1186/s13052-017-0332-5. [PubMed: 28257640]. [PubMed Central: PMC5347820].
  • 22. Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006;44(5):1681-5. doi: 10.1128/JCM.44.5.1681-1685.2006. [PubMed: 16672393]. [PubMed Central: PMC1479182].
  • 23. Hammoud MS, Al-Taiar A, Fouad M, Raina A, Khan Z. Persistent candidemia in neonatal care units: Risk factors and clinical significance. Int J Infect Dis. 2013;17(8):e624-8. doi: 10.1016/j.ijid.2012.11.020. [PubMed: 23276488].
  • 24. Al Thaqafi AH, Farahat FM, Al Harbi MI, Al Amri AF, Perfect JR. Predictors and outcomes of Candida bloodstream infection: Eight-year surveillance, western Saudi Arabia. Int J Infect Dis. 2014;21:5-9. doi: 10.1016/j.ijid.2013.12.012. [PubMed: 24468816].
  • 25. Nucci M, Perfect JR. When primary antifungal therapy fails. Clin Infect Dis. 2008;46(9):1426-33. doi: 10.1086/587101. [PubMed: 18419447].
  • 26. Levy I, Shalit I, Askenazi S, Klinger G, Sirota L, Linder N. Duration and outcome of persistent candidaemia in newborn infants. Mycoses. 2006;49(3):197-201. doi: 10.1111/j.1439-0507.2006.01231.x. [PubMed: 16681810].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments